Skip to main content
OpenTrials

Clinical trial condition

Water-Electrolyte Imbalance

Explore clinical trials studying Water-Electrolyte Imbalance. Study availability and eligibility vary by location and protocol.

499 public trials 50 recruiting studies
Refine in advanced search Browse all conditions

Water-Electrolyte Imbalance trial results

Completed

Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Oral Lixivaptan Capsules in Subject With Euvolemic Hyponatremia

NCT00660959

Conditions
Edema, Hyponatremia, Hyponatremia With Normal Extracellular Fluid Volume, +5 more
Locations
  • Research Site 1 Mobile, Alabama, United States
  • PsyPharma Global Phoenix, Arizona, United States
  • Research Site Los Angeles, California, United States
  • Research Site 1 Los Angeles, California, United States
View all 71 locations
View Trial Details
Completed

A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of Oral Lixivaptan Capsules in Subjects With Euvolemic Hyponatremia

NCT00876798

Conditions
Brain Diseases, Central Nervous System Diseases, Endocrine System Diseases, +8 more
Locations
  • Birmingham Nursing and Rehabilitation East Birmingham, Alabama, United States
  • Healthscan Research, LLC Montgomery, Alabama, United States
  • PsyPharma Clinical Research, Inc. Phoenix, Arizona, United States
  • PsyPharma Clinical Research Phoenix, Arizona, United States
View all 90 locations
View Trial Details
Completed

THE BALANCE Study: Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient Evaluation

NCT00578695

Conditions
Cardiovascular Diseases, Edema, Heart Diseases, +7 more
Locations
  • Research Site 1 Birmingham, Alabama, United States
  • Research Site 1 Birmingham, Alabama, United States
  • Research Site 1 Mobile, Alabama, United States
  • Research Site 1 Bakersfield, California, United States
View all 287 locations
View Trial Details
Completed

International, Multicenter Study of a Twenty-eight Week, Open-label, Titrated Oral Lixivaptan Administration in Patients With Chronic Hyponatremia: Extension to Studies CK-LX3401, 3405, and 3430

NCT01056848

Conditions
Brain Diseases, Central Nervous System Diseases, Endocrine System Diseases, +9 more
Locations
  • Torrance Clinical Research Lomita, California, United States
  • Innovative Research of West Florida Clearewater, Florida, United States
  • Fleming Island Center for Clinical Research Fleming Island, Florida, United States
  • Jacksonville Center for Clinical Research Jacksonville, Florida, United States
View Trial Details

Related conditions